Technical Analysis for AVXL - Anavex Life Sciences Corp.

Grade Last Price % Change Price Change
C 9.62 3.78% 0.35
AVXL closed up 3.78 percent on Friday, May 20, 2022, on approximately normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Crossed Above 20 DMA Bullish 3.78%
Wide Bands Range Expansion 3.78%
Fell Below 20 DMA Bearish 10.32%
Wide Bands Range Expansion 10.32%
Gapped Down Weakness 10.32%
1,2,3 Retracement Bearish Bearish Swing Setup 2.01%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.01%
Crossed Above 20 DMA Bullish 2.01%
NR7 Range Contraction 2.01%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Anavex Life Sciences Corp. Description

Anavex Life Sciences Corp., a biopharmaceutical company, is engaged in the discovery and development of drugs for the treatment of Alzheimer's disease, central nervous system diseases, and pain and various cancers. Its lead drug candidates include ANAVEX 2-73 and ANAVEX PLUS, a combination of ANAVEX 2-73 with donepezil (Aricept), which is in a Phase IIa clinical trial for the treatment of Alzheimer's disease. The company's product candidates also include ANAVEX 3-71, a drug candidate that is effective in very small doses against the major Alzheimer's hallmarks in transgenic (3xTg-AD) mice via sigma-1 receptor activation and M1 muscarinic allosteric modulation; ANAVEX 1-41, a sigma-1 agonist for neuroprotective application; and ANAVEX 1037, ANAVEX 1079, and ANAVEX 1519 for the treatment of pain and various cancers. Anavex Life Sciences Corp. was founded in 2006 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Pain Chemical Compounds Neuroscience Alzheimer's Disease Alzheimer's Central Nervous System Disease Lewy Body Dementia Piperidines Treatment Of Alzheimer's Disease Neuroprotection

Is AVXL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 31.5
52 Week Low 7.13
Average Volume 887,463
200-Day Moving Average 15.25
50-Day Moving Average 10.55
20-Day Moving Average 8.77
10-Day Moving Average 8.47
Average True Range 0.76
RSI 52.38
ADX 31.16
+DI 18.05
-DI 19.41
Chandelier Exit (Long, 3 ATRs) 8.36
Chandelier Exit (Short, 3 ATRs) 9.41
Upper Bollinger Bands 10.16
Lower Bollinger Band 7.37
Percent B (%b) 0.81
BandWidth 31.77
MACD Line -0.41
MACD Signal Line -0.65
MACD Histogram 0.2366
Fundamentals Value
Market Cap 579.03 Million
Num Shares 60.2 Million
EPS -0.60
Price-to-Earnings (P/E) Ratio -16.09
Price-to-Sales 0.00
Price-to-Book 12.68
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.70
Resistance 3 (R3) 10.59 10.13 10.52
Resistance 2 (R2) 10.13 9.85 10.18 10.46
Resistance 1 (R1) 9.87 9.68 10.00 9.98 10.40
Pivot Point 9.41 9.41 9.47 9.46 9.41
Support 1 (S1) 9.15 9.13 9.28 9.26 8.84
Support 2 (S2) 8.69 8.96 8.74 8.78
Support 3 (S3) 8.43 8.69 8.72
Support 4 (S4) 8.54